Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Cunningham

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Law and Human Behavior|March 24, 2007
Capital offenders in Texas prisons: rates, correlates, and an actuarial analysis of violent misconductMark Douglas Cunningham, Jon R Sorensen
Applied and Environmental Microbiology|January 1, 1988
Induction of Xylose Reductase and Xylitol Dehydrogenase Activities in Pachysolen tannophilus and Pichia stipitis on Mixed SugarsPaul A Bicho, P Lynn Runnals, J Douglas Cunningham, et al.
Children (Basel, Switzerland)|July 2, 2021
Aerosolized Surfactant for Preterm Infants with Respiratory Distress SyndromeMandy Brasher, Thomas M Raffay, M Douglas Cunningham, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 13, 2019
Neonatal postgraduate training program for physician assistants: meeting a need in neonatal careElie G Abu Jawdeh, Frances Hardin-Fanning, Tria B Kinnard, et al.
Chemical Communications (Cambridge, England)|May 27, 2005
Nanoparticle-coated microcrystalsMuthu Murugesan, Douglas Cunningham, José-Luis Martinez-Albertos, et al.
Children (Basel, Switzerland)|April 3, 2021
Extubation Readiness in Preterm Infants: Evaluating the Role of Monitoring Intermittent HypoxemiaElie G Abu Jawdeh, Amrita Pant, Aayush Gabrani, et al.
The Journal of Pediatrics|April 1, 2024
Predicting Extubation Readiness in Preterm Infants Utilizing Machine Learning: A Diagnostic Utility StudyMandy Brasher, Alexandr Virodov, Thomas M Raffay, et al.
IEEE Transactions on Visualization and Computer Graphics|May 11, 2013
Visualizing natural image statisticsHui Fang, Gary Kwok-Leung Tam, Rita Borgo, et al.
Antiviral Research|July 7, 2019
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1Joseph J Eron, Chloe Orkin, Douglas Cunningham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2025
Doravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, randomized, controlled, double-blind, non-inferiority trialJürgen K Rockstroh, Roger Paredes, Pedro Cahn, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Law and Human Behavior|March 24, 2007
Capital offenders in Texas prisons: rates, correlates, and an actuarial analysis of violent misconductMark Douglas Cunningham, Jon R Sorensen
Applied and Environmental Microbiology|January 1, 1988
Induction of Xylose Reductase and Xylitol Dehydrogenase Activities in Pachysolen tannophilus and Pichia stipitis on Mixed SugarsPaul A Bicho, P Lynn Runnals, J Douglas Cunningham, et al.
Children (Basel, Switzerland)|July 2, 2021
Aerosolized Surfactant for Preterm Infants with Respiratory Distress SyndromeMandy Brasher, Thomas M Raffay, M Douglas Cunningham, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 13, 2019
Neonatal postgraduate training program for physician assistants: meeting a need in neonatal careElie G Abu Jawdeh, Frances Hardin-Fanning, Tria B Kinnard, et al.
Chemical Communications (Cambridge, England)|May 27, 2005
Nanoparticle-coated microcrystalsMuthu Murugesan, Douglas Cunningham, José-Luis Martinez-Albertos, et al.
Children (Basel, Switzerland)|April 3, 2021
Extubation Readiness in Preterm Infants: Evaluating the Role of Monitoring Intermittent HypoxemiaElie G Abu Jawdeh, Amrita Pant, Aayush Gabrani, et al.
The Journal of Pediatrics|April 1, 2024
Predicting Extubation Readiness in Preterm Infants Utilizing Machine Learning: A Diagnostic Utility StudyMandy Brasher, Alexandr Virodov, Thomas M Raffay, et al.
IEEE Transactions on Visualization and Computer Graphics|May 11, 2013
Visualizing natural image statisticsHui Fang, Gary Kwok-Leung Tam, Rita Borgo, et al.
Antiviral Research|July 7, 2019
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1Joseph J Eron, Chloe Orkin, Douglas Cunningham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2025
Doravirine/islatravir (100/0.75 mg) once-daily compared to bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment: 48-week results from a phase 3, randomized, controlled, double-blind, non-inferiority trialJürgen K Rockstroh, Roger Paredes, Pedro Cahn, et al.
Pageof 1